CompletedNot Applicable

Treatment of Chronic Mountain Sickness

France60 participantsStarted 2020-02-15

Plain-language summary

This study aims to assess the effect of two drugs for the treatment of chronic mountain sickness in highlanders.

Who can participate

Age range18 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male * Age between 18 and 55 yrs * Body mass index \<30kg/m² * Born at \>3500 m, living for \>3 years at the local high altitude * No diagnosis of cardiorespiratory, metabolic or neurological diseases * No drug intake * No smoker * Chronic mountain sickness score ≥6 Exclusion Criteria: * Diagnosis of cardiorespiratory, metabolic and neurological diseases * Systolic \> 130 mmHg and/or diastolic \> 85 mmHg blood pressure * Drug intake * Smoker * Chronic mountain sickness score \<6

What they're measuring

Change in hematocrit

Timeframe: Change from before to after 9 months of treatment

Trial details

NCT IDNCT04251364

SponsorCentre d'Expertise sur l'Altitude EXALT

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-30

View on ClinicalTrials.gov More Hypoxia, Altitude trials